Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Pages

Shots - Health News
2:16 pm
Wed January 9, 2013

Alzheimer's Drug Dials Back Deafness In Mice

If you know some mice that took This Is Spinal Tap too literally, they might want to know about an experiment to restore hearing with a failed Alzheimer's drug.
The Kobal Collection

Originally published on Mon April 8, 2013 8:34 am

If you've spent years CRANKING YOUR MUSIC UP TO 11, this item's for you.

A drug developed for Alzheimer's disease can partially reverse hearing loss caused by exposure to extremely loud sounds, an international team reports in the journal Neuron.

Before you go back to rocking the house with your Van Halen collection, though, consider that the drug has only been tried in mice so far. And it has never been approved for human use.

Read more
Environment
3:29 am
Mon December 31, 2012

A Busy And Head-Scratching 2012 Hurricane Season

This satellite image from Oct. 28 shows Hurricane Sandy in the Atlantic Ocean before making landfall.
NASA via Getty Images

Originally published on Mon December 31, 2012 5:46 am

Superstorm Sandy is what most people will remember from the 2012 Atlantic hurricane season. But Sandy was just one of 10 hurricanes this year — a hurricane season that was both busy and strange.

Late summer is when the hurricane season usually gets busy. But Greg Jenkins, a professor of atmospheric science at Howard University, says this year was different.

Read more
Shots - Health News
3:22 pm
Wed December 26, 2012

Despite Uneven Results, Alzheimer's Research Suggests A Path For Treatment

Brain scans using Amyvid dye to highlight beta-amyloid plaques in the brain. Clockwise from top left: a cognitively normal subject; an amyloid-positive patient with Alzheimer's disease; a patient with mild cognitive impairment who progressed to dementia during a study; and a patient with mild cognitive impairment.
Slide courtesy of the journal Neurology

Originally published on Wed December 26, 2012 7:24 pm

It's been a mixed year for Alzheimer's research. Some promising drugs failed to stop or even slow the disease. But researchers also found reasons to think that treatments can work if they just start sooner.

Scientists who study Alzheimer's say they aren't discouraged by the drug failures. "I actually think it was a phenomenal year for research," says Bill Rebeck, a brain scientist at Georgetown University.

Read more
Shots - Health News
3:59 pm
Fri December 21, 2012

Killer's DNA Won't Explain His Crime

A person's DNA can say a lot about a person, but not why someone has committed a horrific crime like mass murder.
iStockphoto.com

Originally published on Fri December 21, 2012 9:21 pm

Connecticut's chief medical examiner, Wayne Carver, has raised the possibility of requesting genetic tests on Adam Lanza, the man responsible for the shootings at Sandy Hook Elementary School.

Carver hasn't said precisely what he may want geneticists to look for, but scientists who study the links between genes and violence say those tests won't reveal much about why Lanza did what he did.

Read more
Shots - Health News
3:36 am
Mon December 17, 2012

Experts Argue Against Proposed Ban On Vaccine Preservative

A boy in Lima, Peru, receives a hepatitis B vaccine during an immunization drive in 2008. The United Nations is considering a ban on the preservative thimerosal, which is often used in hepatitis B and other vaccines in developing countries.
Martin Mejia AP

Originally published on Mon December 17, 2012 8:55 am

An old complaint about the safety of childhood vaccines is finding new life at the United Nations.

The U.N. Environment Program is considering a ban on thimerosal, a vaccine preservative that is widely used in developing countries. The program expects to make a decision sometime after a final meeting on the issue in January.

Read more

Pages